A phase Ib study of JS001, a humanized IgG4 mAb against programmed death-1 (PD-1) combination with axitinib in patients with metastatic mucosal melanoma.

作者:Jun, Guo; Xinan, Sheng; Lu, Si; Yan, Kong; Zhihong, Chi; Chuanliang, Cui; Bixia, Tang; Xieqiao, Yan; Li Li, Mao; Bin, Lian; Xuan, Wang; Siming, Li; Li, Zhou; Xue, Bai; Jie, Dai
来源:Journal of Clinical Oncology, 2018, 36(15_suppl): 9528-9528.
DOI:10.1200/jco.2018.36.15_suppl.9528